Top Markets
Coin of the day
IntegraGen SA IntegraGen SA

IntegraGen SA

ALINT
株式のランク #19673
IntegraGen SA provides human genome analysis services for academic researcher... IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. IntegraGen SA is a subsidiary of OncoDNA SA.
株価
$0.20876331
時価総額
$1.38M
変化(1日)
1.15%
変化(1年)
-64.84%
FR
取引 IntegraGen SA (ALINT)

カテゴリー

IntegraGen SA(ALINT)の利益
Dec 2025 時点の利益 TTM: $-3.23M
IntegraGen SA の最新の財務報告によると、同社の現在の利益は $-3.23M です。2023 年には $-286.40K の利益を上げ、これは 2022 年の利益 $-153.95K と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
IntegraGen SA の利益の推移(2008 〜 2026)
各年末の利益
利益 変化
2026 (TTM) $-3.23M 782.69%
2024 $-366.28K 27.89%
2023 $-286.40K 86.04%
2022 $-153.95K 18.42%
2021 $-130.00K -77.17%
2020 $-569.29K 15.84%
2019 $-491.43K -67.91%
2018 $-1.53M 6.75%
2017 $-1.43M -29.04%
2016 $-2.02M 0.08%
2015 $-2.02M 10.76%
2014 $-1.82M -54.01%
2013 $-3.96M 29.95%
2012 $-3.05M -5.30%
2011 $-3.22M -31.40%
2010 $-4.70M -3.84%
2009 $-4.88M -6.08%
2008 $-5.20M 0.00%
同業他社の利益
企業 利益 利益の差
$24.72B -764,615.67%
DK
$5.17B -159,875.15%
US
$5.16B -159,602.96%
US
$2.14B -66,218.92%
BE
$1.66B -51,304.66%
NL